Smooth Muscle Dysfunction in Patients Older than 54 Years of Age with Objective Evidence of Arteriosclerosis

D. Akamatsu, A. Satou, T. Watanabe, E. Hashizume, H. Gotou, S. Satomi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: This investigation was designed to assess the relationship between flow-mediated vasodilatation (FMD) and nitroglycerin (NTG)-mediated vasodilatation (NMD) with atherosclerotic risk factors. Methods: FMD and NMD were measured in 75 subjects including 57 patients with atherosclerotic disease (AAA/PAOD = 30/27, age 72 ± 7 years) and 18 controls. Brachial response to hyperemia and NTG were measured every minute after cuff deflation and NTG administration. Results: In the 75 subjects, responses to NTG showed a sigmoid curve. Only 2 cases reached maximal diameter within 4 minutes after NTG, and 90% of the cases reached maximal diameter at 6 minutes or later (7.5 ± 2.0 minutes). In patients with atherosclerotic disease, a multiple regression analysis showed higher FMD was associated with higher NMD, and higher NMD was associated with smaller vessel size, lower systolic blood pressure, higher FMD, lower carotid maximal IMT, lower serum levels of insulin, and lower HOMA-IR. Conclusions: In subjects older than 54, NMD measured at 3 or 4 minutes after NTG administration would underestimate the NTG-dependent vasodilatation. NMD measured with the maximal responded diameter was associated with atherosclerotic risk factors, and it is therefore considered to be an important parameter in patients with atherosclerotic disease.

Original languageEnglish
Pages (from-to)639-645
Number of pages7
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume34
Issue number6
DOIs
Publication statusPublished - 2007 Dec 1

Keywords

  • Endothelial function
  • FMD
  • NMD
  • Smooth muscle function

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Smooth Muscle Dysfunction in Patients Older than 54 Years of Age with Objective Evidence of Arteriosclerosis'. Together they form a unique fingerprint.

  • Cite this